NCT03240913

Brief Summary

The primary objectives of this study are to: 1) develop an educational tool known as the Patient Reported Outcome Measure informed Decision Aid (PROM-DA) that will describe the options for patients considering total knee arthroplasty (TKA) surgery, and help them imagine what to expect if they choose either option; 2) assess the extent that the PROM-DA improves patients decision quality; 3) determine the feasibility of a larger trial to test the PROM-DA in multiple sites and more patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
163

participants targeted

Target at P75+ for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jun 2017

Typical duration for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 19, 2017

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

July 27, 2017

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 7, 2017

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 18, 2018

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

March 3, 2020

Completed
Last Updated

April 28, 2020

Status Verified

April 1, 2020

Enrollment Period

1.3 years

First QC Date

July 27, 2017

Last Update Submit

April 24, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • Decision quality

    Hip and Knee Decision Quality Instrument (HK-DQI)

    40 to 52 weeks after baseline

Secondary Outcomes (16)

  • Quality of life (generic)

    40 to 52 weeks after baseline

  • Quality of life (condition-specific)

    40 to 52 weeks after baseline

  • Depression

    40 to 52 weeks after baseline

  • Knowledge about total knee arthroplasty surgery

    Baseline

  • Values

    Baseline

  • +11 more secondary outcomes

Study Arms (2)

Treatment Group

EXPERIMENTAL
Behavioral: Baseline and Follow-up SurveysOther: Patient Reported Outcome Measure informed Decision Aid

Non Treatment Group

PLACEBO COMPARATOR

Conventional information

Behavioral: Baseline and Follow-up SurveysOther: Pamphlet

Interventions

(completed online)

Non Treatment GroupTreatment Group

(usual care)

Non Treatment Group

Eligibility Criteria

Age30 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (age≥30) patients with knee osteoarthritis (OA)
  • Have an appointment with a surgeon for consultation about Total Knee Arthroplasty at the Edmonton Bone and Joint Centre
  • Understands, speaks and reads English; and
  • Able to provide informed consent.

You may not qualify if:

  • Individuals who have had prior total knee arthroplasty
  • Physician-diagnosed Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Fibromyalgia, or Gout.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Edmonton Bone and Joint Centre

Edmonton, Alberta, T5E 5R8, Canada

Location

Related Publications (1)

  • Bansback N, Trenaman L, MacDonald KV, Hawker G, Johnson JA, Stacey D, Marshall DA. An individualized patient-reported outcome measure (PROM) based patient decision aid and surgeon report for patients considering total knee arthroplasty: protocol for a pragmatic randomized controlled trial. BMC Musculoskelet Disord. 2019 Feb 23;20(1):89. doi: 10.1186/s12891-019-2434-2.

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

BaseLine dental cement

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 27, 2017

First Posted

August 7, 2017

Study Start

June 19, 2017

Primary Completion

October 18, 2018

Study Completion

March 3, 2020

Last Updated

April 28, 2020

Record last verified: 2020-04

Data Sharing

IPD Sharing
Will not share

Locations